| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Africa CDC's viral hepatitis prevention and control programme: a continental initiative to support elimination programmes
|
Tesfahunei, Hanna Amanuel
|
|
|
9 |
4 |
p. 284-286
|
artikel
|
| 2 |
A new tool for assessing hepatitis B treatment eligibility in Africa
|
Ouoba, Serge
|
|
|
9 |
4 |
p. 277-278
|
artikel
|
| 3 |
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
|
Yau, Thomas
|
|
|
9 |
4 |
p. 310-322
|
artikel
|
| 4 |
Can genetically engineered pig livers offer patients precious time?
|
Furlow, Bryant
|
|
|
9 |
4 |
p. 295
|
artikel
|
| 5 |
Comprehensive screening for superficial oesophageal squamous cell carcinoma and precancerous lesions
|
Murakami, Daisuke
|
|
|
9 |
4 |
p. 291-292
|
artikel
|
| 6 |
Comprehensive screening for superficial oesophageal squamous cell carcinoma and precancerous lesions – Authors' reply
|
Yuan, Xiang-Lei
|
|
|
9 |
4 |
p. 292
|
artikel
|
| 7 |
Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial
|
Terlouw, Luke G
|
|
|
9 |
4 |
p. 299-309
|
artikel
|
| 8 |
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study
|
Minier, Nicolas
|
|
|
9 |
4 |
p. 323-332
|
artikel
|
| 9 |
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
|
Marshall, Alison D
|
|
|
9 |
4 |
p. 366-382
|
artikel
|
| 10 |
Eliminating viral hepatitis: no room for complacency
|
Brierley, Rob
|
|
|
9 |
4 |
p. 279-280
|
artikel
|
| 11 |
Expression of concern—Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
|
The Editors of The Lancet Gastroenterology & Hepatology,
|
|
|
9 |
4 |
p. 288
|
artikel
|
| 12 |
Gluten and non-coeliac gluten sensitivity: the nocebo effect and future avenues
|
Mennini, Maurizio
|
|
|
9 |
4 |
p. 292-293
|
artikel
|
| 13 |
Gluten and non-coeliac gluten sensitivity: the nocebo effect and future avenues – Authors' reply
|
de Graaf, Marlijne C G
|
|
|
9 |
4 |
p. 293-294
|
artikel
|
| 14 |
Haematopoietic stem-cell transplantation for patients with Crohn's disease: primum non nocere
|
Ciccocioppo, Rachele
|
|
|
9 |
4 |
p. 278-279
|
artikel
|
| 15 |
Harnessing the power of civil society to achieve hepatitis elimination
|
Adda, Danjuma
|
|
|
9 |
4 |
p. 281-282
|
artikel
|
| 16 |
Infinite Life
|
Moody, Joe
|
|
|
9 |
4 |
p. 298
|
artikel
|
| 17 |
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
|
Cooke, Graham S
|
|
|
9 |
4 |
p. 346-365
|
artikel
|
| 18 |
Research in Brief
|
Baker, Holly
|
|
|
9 |
4 |
p. 296
|
artikel
|
| 19 |
Resmetirom for NASH: balancing promise and prudence
|
The Lancet Gastroenterology & Hepatology,
|
|
|
9 |
4 |
p. 273
|
artikel
|
| 20 |
Robust data on stenting for patients with chronic mesenteric ischaemia
|
Mendes, Bernardo C
|
|
|
9 |
4 |
p. 274-275
|
artikel
|
| 21 |
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
|
Lindsay, James O
|
|
|
9 |
4 |
p. 333-345
|
artikel
|
| 22 |
The COSMIC-312 study: will it shape future combination therapies for advanced hepatocellular carcinoma?
|
Saborowski, Anna
|
|
|
9 |
4 |
p. 275-276
|
artikel
|
| 23 |
The DESTIN trial: to step up or not?
|
Tiwari, Avinash
|
|
|
9 |
4 |
p. 289-290
|
artikel
|
| 24 |
The DESTIN trial: to step up or not?
|
Cahyadi, Oscar
|
|
|
9 |
4 |
p. 289
|
artikel
|
| 25 |
The DESTIN trial: to step up or not? – Authors' reply
|
Bang, Ji Young
|
|
|
9 |
4 |
p. 290-291
|
artikel
|
| 26 |
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection
|
Delphin, Marion
|
|
|
9 |
4 |
p. 383-392
|
artikel
|
| 27 |
Urgent need for lived experience in hepatitis B guideline development
|
Freeland, Catherine
|
|
|
9 |
4 |
p. 282-284
|
artikel
|
| 28 |
WHO hepatitis C elimination targets: the global equity challenge
|
Heath, Katherine
|
|
|
9 |
4 |
p. 286-288
|
artikel
|
| 29 |
You Are What You Eat: a Twin Experiment
|
Sherwood-Martin, Hollie
|
|
|
9 |
4 |
p. 297
|
artikel
|
Tijdschrift beschrijving